Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B

Lamivudine is a potent nucleoside analogue used in treating chronic hepatitis B (CHB). However, resistance to the drug remains a problem. We analyzed all lamivudine recipients in this trial to determine the baseline characteristics and a model to predict early virological response reflecting the lon...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Clin Exp Med
Glavni autori: Zhou, Rui, Pan, Fan, Lin, Chun, Lin, Xiuquan, Gao, Haibing, Huang, Shuiwen, Huang, Zuxiong, Lin, Yong, Pan, Chen, Zhou, Yuanping
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694462/
https://ncbi.nlm.nih.gov/pubmed/26770562
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items